Quantcast
Home / Practice Areas / Business and Civil Practice / Study raises new questions about Zetia, Vytorin

Study raises new questions about Zetia, Vytorin

A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.